Photo Rounds

Patient with intractable nausea and vomiting

Author and Disclosure Information

 

References

Pharmacologic therapy, the least effective treatment option, is recommended for patients who are unwilling or unable to undergo myotomy and/or dilation and do not respond to botulinum toxin.6,7 Long-acting nitrates such as isosorbide, calcium channel blockers such as nifedipine, and phosphodiesterase-5 (PDE5) inhibitors such as sildenafil reduce lower esophageal sphincter tone and pressure.

A chest x-ray will show an absence of gastric air, and occasionally, as in this case, a tubular mass (the dilated esophagus) behind the heart and aorta.

Both nifedipine and isosorbide should be taken sublingually before meals (30 minutes and 10 minutes, respectively). The effects of nifedipine and isosorbide, however, are partial, and these agents do not provide complete relief from symptoms.6 PDE5 use has been limited and results are inconclusive.

Our patient. The food particles in the patient’s esophagus were removed during endoscopy, and she stopped vomiting completely. Based on the findings and clinical picture, the patient most likely suffered from mega-esophagus (an end-stage dilated malfunctioning esophagus). Our patient was discharged to follow-up with her gastroenterologist.

Because there is no definitive treatment for achalasia, the patient was counseled about the need for continuous monitoring and dietary precautions, including modification of food texture or change of fluid viscosity. Food may be chopped, minced, or pureed, and fluids may be thickened.

CORRESPONDENCE
Hossein Akhondi, MD, FACP, Georgetown University, 1010 Mass Ave, NW, Unit 904, Washington, DC 20001; h68akhond@hotmail.com.

Pages

Recommended Reading

Leading scope manufacturer to pay hefty settlement for alleged kickbacks, bribery
MDedge Family Medicine
Study: 2.6% of patients discharged from U.S. hospital used probiotics
MDedge Family Medicine
Lessons from the Indiana HIV/HCV outbreak
MDedge Family Medicine
Birth-cohort HCV testing misses one-quarter of infections
MDedge Family Medicine
Test all kidney transplant patients for hepatitis E
MDedge Family Medicine
Privacy measure inadvertently suppresses substance abuse data
MDedge Family Medicine
Better control of asymptomatic C. difficile needed in communities
MDedge Family Medicine
Mongersen could be an impressive new treatment for inflammatory bowel disease
MDedge Family Medicine
Sulindac plus erlotinib reduces duodenal polyp burden
MDedge Family Medicine
Screening for parasitic infections: One doctor’s experience
MDedge Family Medicine